序号 | 論文名稱 | 刊物名稱及ISSN号 | 發表年份-卷-期-頁 | 本人 排名 |
1 | WNT5B exerts oncogenic effects and is negatively regulated by miR-5587-3p in lung adenocarcinoma progression. | Oncogene. | 2020 39(7):1484-1497 | 共同通訊 |
2 | LncRNA GMDS-AS1 inhibits lung adenocarcinoma development by regulating miR-96-5p/CYLD signaling. | Cancer Med. | 2020 9(3):1196-1208 | 共同通訊 |
3 | Geranylgeranyl diphosphate synthase 1 knockout ameliorates ventilator-induced lung injury via regulation of TLR2/4-AP-1 signaling. | Free Radic Biol Med. | 2020 147():159-166 | 共同通訊 |
4 | The Diagnostic Yield of Closed Needle Pleural Biopsy in Exudative Pleural Effusion: A Retrospective 10-year Study. | Ann Transl Med | 2020 Apr;8(7):491. | 通訊作者 |
5 | Treatment with convalescent plasma for COVID-19 patients in Wuhan, China. | Med Virol. | 2020 Apr 15:10.1002/jmv.25882. Online ahead of print. | 通訊作者 |
6 | Encephalitis as a clinical manifestation of COVID-19. | Brain Behav Immun. | 2020 Apr 10:S0889-1591(20)30465-7. Online ahead of print. | 通訊作者 |
7 | Prolonged SARS-CoV-2 RNA shedding: Not a rare phenomenon. | Med Virol. | 2020 Apr 29:10.1002/jmv.25952. Online ahead of print. | 通訊作者 |
8 | Zebrafish Xenograft Model of Human Lung Cancer for Evaluating Osimertinib Resistance. | Biomed Res Int. 2314-6133 | 2019():3129748 | 共同通訊 |
9 | Treatment of uncommon mutations in non-small cell lung cancer: new evidence and treatment. | Transl Lung Cancer Res. 2218-6751 | 2019,8(3):302-316 | 共同通訊 |
10 | Efficacy of rapid on-site evaluation for diagnosing pulmonarylesions and mediastinal lymph nodes: a systematic review andmeta-analysis | Transl Lung Cancer Res. 2218-6751 | 2019,8(6):1029-1044 | 通訊作者 |
11 | Downregulation of GSDMD attenuates tumor proliferation via the intrinsic mitochondrial apoptotic pathway and inhibition of EGFR/Akt signaling and predicts a good prognosis in non small cell lung cancer. | Oncol Rep. 1021-335X | 2018,40(4):1971-1984. | 共同通訊 |
12 | Expression profiles and clinical value of plasma exosomal Tim-3 and Galectin-9 in non-small cell lung cancer. | Biochem Biophys Res Commun. 0006-291X | 2018,498(3):409-415. | 共同通訊 |
13 | The correlation between crizotinib efficacy and molecular heterogeneity by next-generation sequencing in non-small cell lung cancer. | J Thorac Dis. 2072-1439 | 2018,10(5):2948-2959. | 第一作者 |
14 | RNA sequencing enables systematic identification of platelet transcriptomic alterations in NSCLC patients. | Biomedicine & Pharmacotherapy. 0753-3322 | 2018,105 (2018) 204–214. | 共同通訊 |
15 | TEAD4 exerts pro-metastatic effects and is negatively regulated by miR6839-3p in lung adenocarcinoma progression. | J Cell Mol Med. 1582-4934 | 2018,22(7):3560-3571. | 共同通訊 |
16 | Comparison of clinical and radiological characteristics between anaplastic lymphoma kinase rearrangement and epidermal growth factor receptor mutation in treatment naïve advanced lung adenocarcinoma | J Thorac Dis 2072-1439 | 2017,9(10):3927-3937 | 共同通訊 |
17 | Patterns and functional implications of platelets upon tumor "education" | Int J Biochem Cell Biol 1357-2725 | 2017,90:68-80 | 共同通訊 |
18 | Erlotinib-based doublet targeted therapy versus erlotinib alone in previously treated advanced non-small-cell lung cancer: a meta-analysis from 24 randomized controlled trials | Oncotarget 1949-2553 | 2017,8(42):73258-73270 | 共同通訊 |
19 | Protein regulator of cytokinesis-1 expression: prognostic value in lung squamous cell carcinoma patients | J Thorac Dis 2072-1439 | 2017,9(7):2054-2060 | 共同通訊 |
20 | PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/β-catenin signaling pathway | Mol Cancer 1476-4598 | 2017,16(1):108 | 共同通訊 |
21 | NCAPG2 promotes tumour proliferation by regulating G2/M phase and associates with poor prognosis in lung adenocarcinoma | J Cell Mol Med 1582-4934 | 2017,21(4):665-676 | 共同通訊 |
22 | Long intergenic noncoding RNA 00673 promotes non-small-cell lung cancer metastasis by binding with EZH2 and causing epigenetic silencing of HOXA5 | Oncotarget 1949-2553 | 2017,8(20):32696-32705 | 共同通訊 |
23 | Detection of oncogenic mutations in resected bronchial margins by next-generation sequencing indicates early relapse in stage IA lung adenocarcinoma patients | Oncotarget 1949-2553 | 2017,8(25):40643-40653 | 共同一作 |
24 | Long non-coding RNA 00312 regulated by HOXA5 inhibits tumour proliferation and promotes apoptosis in Non-small cell lung cancer | J Cell Mol Med 1582-4934 | 2017,21(9):2184-2198 | 共同一作 |
25 | Pulmonary ground-glass opacity: computed tomography features, histopathology and molecular pathology. | Transl Lung Cancer Res. 2218-6751 | 2017,6(1):68-75. | 共同通訊 |
26 | Correlation in histological subtypes with high resolution computed tomography signatures of early stage lung adenocarcinoma. | Transl Lung Cancer Res. 2218-6751 | 2017,6(1):14-22. | 共同通訊 |
27 | Transthoracic needle aspiration in solitary pulmonary nodule. | Transl Lung Cancer Res. 2218-6751 | 2017,6(1):76-85. | 共同通訊 |
28 | How to diagnose pulmonary nodules: from screening to therapy. | Transl Lung Cancer Res. 2218-6751 | 2017,6(1):3-5. | 共同通訊 |
29 | The pulmonary nodule ""discovered"" by pneumonia: a case rep | Transl Lung Cancer Res. 2218-6751 | 2017,6(1):92-96. | 共同通訊 |
30 | Comparison between endobronchial ultrasound-guided transbronchial biopsy and CT-guided transthoracic lung biopsy for the diagnosis of peripheral lung cancer: a systematic review and meta-analysis. | Transl Lung Cancer Res. 2218-6751 | 2017,6(1):23-34. | 共同通訊 |
31 | The imaging of small pulmonary nodules. | Transl Lung Cancer Res. Transl Lung Cancer Res. 2218-6751 | 2017,6(1):62-67. | 共同通訊 |
32 | Circulating long noncoding RNA GAS5 is a novel biomarker for the diagnosis of non-small cell lung cancer | Medicine (Baltimore) 0025-7974 | 2016,95(37):e4608 | 共同一作 |
33 | Upregulation of long intergenic noncoding RNA 00673 promotes tumor proliferation via LSD1 interaction and repression of NCALD in non-small-cell lung cancer | Oncotarget 1949-2553 | 2016,7(18):25558-75 | 共同通訊 |
34 | The role of TWIST1 in epithelial-mesenchymal transition and cancers | Tumour Biol 1010-4283 | 2016,37(1):185-97 | 通訊作者 |
35 | Twist1-mediated 4E-BP1 regulation through mTOR in non-small cell lung cancer | Oncotarget 1949-2553 | 2015,6(32):33006-18 | 共同一作 |
